2014;36: 1244 54. S2.1-8. Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23:1966 72. S2.1-9. Isetts BJ, Buffington DE, Carter BL, et al. Evaluation of pharmacists work in a physician-pharmacist collaborative model for the manage- ment of hypertension. Pharmacotherapy. 2016;36:374 84. S2.1-10. McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008;168:2355 61. S2.1-11. Polgreen LA, Han J, Carter BL, et al. Cost-effectiveness of a physi- cian-pharmacist collaboration intervention to improve blood pres- sure control. Hypertension. 2015;66:1145 51. S2.1-12. Chen EH, Thom DH, Hessler DM, et al. Using the Teamlet Model to improve chronic care in an academic primary care practice. J Gen Intern Med 25 suppl 42010:S610 4. S2.1-13. Kravetz JD, Walsh RF. Team-based hypertension management to improve blood pressure control. J Prim Care Community Health. 2016;7:272 5. S2.1-14. Wan EYF, Fung CSC, Jiao27 FF, et al. Five-year effectiveness of the Multidisciplinary Risk Assessment and Management Programme- Diabetes Mellitus (RAMP-DM) on diabetes-related complications and health service uses a population-based and propensity-matched cohort study. Diabetes Care. 2018;41:49 59. S2.1-15. Buhse S, M ;hlhauser I, Heller T, et al. Informed shared decision- making programme on the prevention of myocardial infarc- tion in type 2 diabetes: a randomised controlled trial. BMJ Open. 2015;5:e009116. S2.1-16. Cooper LA, Roter DL, Carson KA, et al. A randomized trial to improve patient-centered care and hypertension control in underserved pri- mary care patients. J Gen Intern Med. 2011;26:1297 304. S2.1-17. Olomu A, Hart-Davidson W, Luo Z, et al. 